PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-04-30

Date Title Company
30-Apr-2025 PureTech Announces Annual Results for Year Ended December 31, 2024 PureTech Health plc
30-Apr-2025 RetinAI and FVS Announce CE-MDR Certification for Co-developed AI-based Diabetic Retinopathy Screening Algorithm, LuxIA® RetinAI and FVS
30-Apr-2025 UK Company, Stablepharma Ltd, enters Phase 1 Clinical Trials with world-first Fridge-Free Tetanus & Diphtheria Vaccine Stablepharma Ltd
30-Apr-2025 Vapourtec video showcases fully automated peptide synthesis Vapourtec
30-Apr-2025 Veranova Expands Advisory Board with Appointment of Dr. Marvin H. Caruthers Veranova
30-Apr-2025 Domain Therapeutics Presents Novel Data Addressing Key Challenges in Oncology at AACR 2025 Domain Therapeutics
30-Apr-2025 Update on CAPItello-280 Phase III trial of Truqap in metastatic castration-resistant prostate cancer AstraZeneca
30-Apr-2025 Fixed-duration Calquence-based regimens recommended for approval in the EU by CHMP for 1st-line chronic lymphocytic leukaemia AstraZeneca
30-Apr-2025 Rare Disease Day 2025: Rally for Rare Event Recap Worldwide CLinical Trials
30-Apr-2025 Addressing Uncertainty in Survival Studies Cytel
30-Apr-2025 Labcorp Announces 2025 First Quarter Results Labcorp
30-Apr-2025 Novavax Appoints Charles Newton to Board of Directors Novavax
30-Apr-2025 Guru Ramamurthy appointed as new CFO for Bayer’s Crop Science Division Bayer
30-Apr-2025 Sanofi and CD&R close Opella transaction, create global consumer healthcare leader Sanofi
30-Apr-2025 Johnson & Johnson receives FDA approval for IMAAVYTM (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living with generalized myasthenia gravis (gMG) Johnson & Johnson
30-Apr-2025 CHMP recommends EU label update for Roche’s Phesgo to allow administration outside of clinical settings Roche
30-Apr-2025 Roche granted FDA Breakthrough Device Designation for first AI-driven companion diagnostic for non-small cell lung cancer Roche
30-Apr-2025 Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis Gilead
30-Apr-2025 Breaking new ground in mental health research: Oxford University, Boehringer Ingelheim, and Cumulus Neuroscience launch first of its kind study investigating the day-to-day experience of patients with psychiatric disorders Boehringer Ingelheim
30-Apr-2025 GSK makes strong start to 2025 with growth in sales, profits and earnings GSK